A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
PHASE3
This open-label study will evaluate the efficacy and safety of tocilizumab ...
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
N/A
Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the con...
Status
Unknown
Location
University of Ghent, Department of Rheumatology
Start Date
2013-04
Trial ID
NCT01834157
To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
PHASE3
Primary Objective:
To assess, in the same study, the safety of sarilumab a...